drugset / Trial / NCT00680784

HKT-500 in Adult Patients With Ankle Sprain

NCT00680784

Phase 3 Completed 260 enrolled Hisamitsu Pharmaceutical Co., Inc.
RandomizedParallel-groupQuadruple-blind

Summary

The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.

Timeline

Start
2008-04
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule Topical

Indications

No indication recorded.